Quantbot Technologies LP Acquires 55,705 Shares of Calumet, Inc. $CLMT

Quantbot Technologies LP boosted its holdings in shares of Calumet, Inc. (NASDAQ:CLMT) by 364.8% during the third quarter, Holdings Channel.com reports. The institutional investor owned 70,973 shares of the oil and gas company’s stock after acquiring an additional 55,705 shares during the quarter. Quantbot Technologies LP’s holdings in Calumet were worth $1,295,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Amalgamated Bank bought a new position in shares of Calumet during the 2nd quarter worth approximately $37,000. State of Alaska Department of Revenue bought a new stake in Calumet in the 3rd quarter valued at $56,000. Ameritas Investment Partners Inc. acquired a new stake in Calumet during the 2nd quarter valued at $111,000. Bessemer Group Inc. bought a new position in Calumet during the third quarter worth $150,000. Finally, SP Asset Management LLC acquired a new position in shares of Calumet in the second quarter valued at $205,000. 34.41% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CLMT has been the subject of a number of research reports. Weiss Ratings restated a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. TD Cowen increased their price target on shares of Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a report on Thursday. Wall Street Zen cut Calumet from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. Zacks Research raised Calumet from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 6th. Finally, UBS Group reissued a “neutral” rating and set a $26.00 price target on shares of Calumet in a report on Friday, February 13th. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Calumet presently has an average rating of “Hold” and a consensus target price of $24.00.

Calumet Stock Performance

Shares of NASDAQ CLMT opened at $30.29 on Friday. The stock has a market capitalization of $2.63 billion, a P/E ratio of -77.66 and a beta of 1.18. The stock’s fifty day moving average is $23.77 and its 200 day moving average is $20.32. Calumet, Inc. has a 52 week low of $7.68 and a 52 week high of $30.52.

Calumet (NASDAQ:CLMT) last announced its quarterly earnings data on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.24. The firm had revenue of ($3,098.50) million for the quarter, compared to analyst estimates of $1.04 billion. During the same quarter in the previous year, the company earned ($0.47) earnings per share. The company’s quarterly revenue was up 9.4% on a year-over-year basis. Equities research analysts forecast that Calumet, Inc. will post -3.02 earnings per share for the current year.

More Calumet News

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright keeps a “Buy” rating and a $33 price target on CLMT, a level above the current price that supports upside expectations for investors. The firm continues to publish multi-year recovery forecasts despite near-term losses. HC Wainwright Research Coverage
• Neutral Sentiment: Reported short-interest data shows 0 shares short and a 0.0 days-to-cover metric — likely a reporting anomaly. If accurate, negligible short interest removes a potential downside pressure, but the entry appears unreliable and should be viewed cautiously.
• Neutral Sentiment: A FY2029 earnings forecast was published by HC Wainwright (reported on AmericanBankingNews), but the item provides a forward-looking projection without new operational details; useful for modeling but not an immediate catalyst. FY2029 Forecast
• Neutral Sentiment: A PR Newswire release highlights record sales for TRUFUEL®. If TRUFUEL is part of Calumet’s branded products mix, rising consumer/retail sales support longer-term revenue diversification; however, the release is a general industry/brand sales item rather than direct corporate financial guidance. TRUFUEL Record Sales
• Negative Sentiment: TD Cowen raised its price target from $19 to $25 but maintained a “Hold” rating — their $25 target implies downside relative to the current trade level, signaling limited near-term upside from this shop and offering a mixed signal despite the higher target. TD Cowen Target Update
• Negative Sentiment: HC Wainwright materially lowered near- and medium-term EPS forecasts (FY2026, FY2027 and FY2028 revisions downward), trimming FY2026 to a larger loss and reducing FY2028 upside. Those cuts are a direct negative to valuation and short-term expectations despite the maintained Buy rating and $33 target. HC Wainwright EPS Revisions

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.